Comparatively little attention has been paid to the conjunctival toxicity of antibiotics administered at the time of cataract surgery. We have observed the effect of subconjunctival gentamicin and cefuroxime injection, using colour photography in a randomised single blind trial of 121 patients undergoing routine cataract surgery. Our results suggest that a hyperaemic eye is likely to occur about twice as often in patients injected with gentamicin (p<0-001). Gentamicin is associated with more pain postoperatively (p<005). The rational use of antimicrobial prophylaxis for any surgical procedure requires that the risk of infection is high and that the effects of infection are severe.' Most of the studies of the incidence of endophthalmitis following cataract surgery were performed over two decades ago; even then its incidence was low, being of the order of
The rational use of antimicrobial prophylaxis for any surgical procedure requires that the risk of infection is high and that the effects of infection are severe.' Most of the studies of the incidence of endophthalmitis following cataract surgery were performed over two decades ago; even then its incidence was low, being of the order of 1 .30%.2 The use of antibiotic prophylaxis can therefore be justified only on account of the poor visual outcome of intraocular infection. The low incidence of infection has necessitated that clinical trials on the prophylactic use of antibiotics in cataract surgery be performed over many years, with vast numbers of patients, in which it is almost impossible to keep other variables constant, such as advances in surgical technique. Reported therapeutic regimens have varied widely, not only in the choice of antibiotic but also in the route and timing of administration in relation to surgery. As a consequence no completely satisfactory prospective clinical trials have ever been performed.
There is, however, reasonable circumstantial Figure II evidence that prophylactic antibiotics in some form lower the risk of postoperative endophthalmitis. Thus, Allen administration. In their control group of 3798 patients receiving topical antibiotics only 0-45% developed endophthalmitis. The incidence of endophthalmitis following subconjunctival injection varied from 0 37% in 2514 patients given 500000 units penicillin, to 0-56% in 4112 patients given 100 mg chloramphenicol and 0-76% in 1709 patients given 10 mg or 20 mg gentamicm.
It is therefore widely accepted that prophylactic antibiotics in some form lower the incidence of endophthatmitis, and this is largely reflected in current ophthalmological practice. In a recent survey of prominent American cataract surgeons gentamicin administered subconjunctivally proved to be the most popular form of prophylaxis.9
In principle the choice of antibiotic is governed by the bacterial flora likely to cause endophthalmitis and the antibiotic's spectrum, intraocular penetration, and local toxicity. The question of conjunctival toxicity and patient tolerance has been relatively underexplored in the published literature.'0 This study was therefore undertaken to compare the postoperative effects on the conjunctiva of gentamicin or cefuroxime given subconjunctivally at routine uncomplicated cataract and implant surgery. (Fig 2A) and gentamicin to the left eye (Fig 2B) . One of the major differences between the two slides is the oedema in the eye which received gentamicin, which as shown in Table 4 (Tables 1 and 2 ) show good individual agreement over time for both observers (x=0 7). The interobserver results (Table 3) suggest that there were differences in the way that the photographs were being assessed -or, put another way, differences in the interpretation of conjunctival reaction -by the two surgeons. We therefore ascertained whether certain specific features such as oedema and subconjunctival haemorrhage were associated with the antibiotic injected. Table 4 shows that Figure 3C (b) conjunctival oedema was more common after gentamicin injection (p<0001). There was a significant difference in the way that patients with conjunctival oedema were graded (p<001), and this probably accounts for the difference in scoring between the two observers (Table 3) . The cause of the greater conjunctival toxicity of gentamicin is unknown, but could be related either to the way the drug is administered or to a factor intrinsic to the molecule itself. In this study gentamicin was administered in a smaller volume (0 5 ml) than was cefuroxime (1 ml); thus it is unlikely that the volume of administration is important. It may, however, be related to its administration in a solution of low osmolarity (180 mosm/l), compared with that of cefuroxime (505 mosm/1). Equally, pH could be an important factor, since gentamicin is much more acidic (pH 4'5) than is cefuroxime (pH 6'3). Fluorescein angiography (Fig 3) shows that gentamicin causes both capillary closure and leakage, and this may be related to the clinical conjunctival changes. This study has clearly demonstrated the superiority of cefuroxime to gentamicin in terms of conjunctival toxicity and patient tolerance, and there are theoretical advantages in its spectrum and ocular penetration. We therefore recommend the use of cefuroxime rather than gentamicin for the prevention ofendophthalmitis following intraocular surgery.
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